TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Scanbio Ingredients AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
750,638
|
622,733
|
531,145 |
Financial expenses |
110,951
|
78,967
|
67,859 |
Earnings before taxes |
106,094
|
-20,220
|
14,838 |
Total assets |
537,612
|
354,557
|
369,588 |
Current assets |
412,024
|
212,005
|
182,223 |
Current liabilities |
185,144
|
157,719
|
164,932 |
Equity capital |
351,772
|
196,838
|
203,444 |
- share capital |
238,000
![]() |
238,000
![]() |
238,000 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
65.4%
|
55.5%
|
55.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
14.1%
|
-3.2%
|
2.8% |
Return on assets (ROA) |
40.4%
|
16.6%
|
22.4% |
Current ratio |
222.5%
|
134.4%
|
110.5% |
Return on equity (ROE) |
30.2%
|
-10.3%
|
7.3% |
Change turnover |
127,905
|
91,588
|
20,835 |
Change turnover % |
21%
|
17%
|
4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.